Hexagon Nutrition AGM: Key resolutions passed, remuneration revisions fail
Hexagon Nutrition's 33rd AGM on Sep 22, 2026, saw approval for financial statements, dividend declaration, and appointments. However, revisions in remuneration for Arun P. Kelkar, Vikram A. Kelkar, and Nikhil A. Kelkar, along with Arun P. Kelkar's re-appointment as Chairman, failed to pass.
The failure of remuneration revision proposals for key management personnel and the Chairman's re-appointment could lead to uncertainty regarding executive compensation and leadership structure, potentially impacting future operations and strategic decisions.
While several routine resolutions were passed, key proposals regarding remuneration revisions for top management and the re-appointment of the Chairman did not receive the required majority, indicating a mixed outcome.
Hexagon Nutrition Limited held its 33rd Annual General Meeting (AGM) on September 22, 2026, through Video Conferencing. The meeting transacted business as set out in the notice convening the AGM, with remote e-voting available from September 19 to September 21, 2026.
Members approved resolutions concerning the adoption of standalone and consolidated financial statements for FY 2025-26, the re-appointment of Dr. Nikhil Arun Kelkar as Joint Managing Director, the declaration of a dividend for FY 2025-26, the ratification of remuneration for cost auditors for FY 2026-27, the appointment of M/s. N. L. Bhatia & Associates as secretarial auditor, and the appointment of Mr. Raghunath Sawant as Executive Director.
However, resolutions pertaining to the revision in remuneration for Mr. Arun Purushottam Kelkar (Chairman and Executive Director), Mr. Vikram Arun Kelkar (Managing Director), and Dr. Nikhil Arun Kelkar (Joint Managing Director), as well as the re-appointment of Mr. Arun Purushottam Kelkar as Chairman and Director, were not passed with the requisite majority. The alteration of the Articles of Association was approved.
What to do with a filing like this
Hexagon Nutrition Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hexagon Nutrition Limited. Read the original for the full detail.